Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions. (2022)

First Author: Osanlou R

Attributed to: Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2021-055551

PubMed Identifier: 35788071

Publication URI: http://europepmc.org/abstract/MED/35788071

Type: Journal Article/Review

Volume: 12

Parent Publication: BMJ open

Issue: 7

ISSN: 2044-6055